Please login to the form below

Not currently logged in

Lonza appoints pharma COO

Marc Funk replaces Stephan Kutzer

Marc Funk LonzaSwiss life sciences firm Lonza has announced that Stephan Kutzer is to step down as chief operations officer for its pharma and biotech division to be replaced by Marc Funk.

Funk, who is currently the company's chief legal officer, will take over from Kutzer on July 1, 2014.

Richard Ridinger, CEO of Lonza, said: “[Funk] has already successfully managed operational and commercial projects in the pharma and biotech network and has been responsible for global quality in pharma & biotech for more than a year.”

Funk's experience prior to joining Lonza in 2008 includes four years as corporate counsel at Merck Serono.

He was also previously a co-CEO at GeneProt, a now defunct US-based biotech company.

29th April 2014

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....